Air Optix® Night and Day® Aqua Therapeutic Wear | NCT05956535 | Trialant

Air Optix® Night and Day® Aqua Therapeutic Wear | NCT05956535 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
AONDA contact lenses		Lotrafilcon A contact lenses worn therapeutically as a bandage lens in a continuous wear (CW) modality (lenses worn continuously including overnight) as instructed by the eye care professional.	Device: Lotrafilcon A contact lenses
PV2 contact lenses		Balafilcon A contact lenses worn therapeutically as a bandage lens in a continuous wear (CW) modality (lenses worn continuously including overnight) as instructed by the eye care professional.	Device: Balafilcon A contact lenses

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Change from baseline in corneal pain at the Follow-up Visit - Primary exposure	The Investigator will review the subject's chart and document change from baseline in corneal pain at the Follow-up visit as "improved, similar, or worsened." The Baseline Visit is defined as the first visit where the therapeutic contact lens was placed on eye as part of a treatment plan for a corneal condition. The Follow-up Visit is defined as the first visit where the therapeutic contact lens was removed from the eye, or the first visit following the removal of the contact lens if, for example, the contact lens was removed between visits. The primary exposure is defined as the first exposure to the study lens if, for example, there were multiple exposures to the study lens. The data collection period consists of any timeframe since and including 2009.	Baseline, Follow-up Visit (up to 1 year following the Baseline Visit)

Contacts/Locations Module

Condition Browse Module